Understanding ST7-OT4: A Non-Coding RNA Molecule with Potential as A Drug Target and Biomarker

Target Name: ST7-OT4

NCBI ID: G338069

ST7-OT4

Other Name(s): NCRNA00042 | ST7OT4 | ST7 overlapping transcript 4

Understanding ST7-OT4: A Non-Coding RNA Molecule with Potential as A Drug Target and Biomarker

ST7-OT4 (NCRNA00042) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression patterns have made it an attractive target for researchers to study and develop new treatments.

ST7-OT4 is a small non-coding RNA molecule that is expressed in various tissues and organs, including the brain, heart, liver, and pancreas. It is characterized by a unique structure that consists of a long stem-loop and a smaller loop that is composed of a series of alternating A and U residues. This unique structure has made it an ideal candidate for drug targeting, as drugs can be designed to interact with specific regions of the molecule.

In addition to its unique structure, ST7-OT4 has also been shown to play a crucial role in several diseases. For example, studies have shown that ST7-OT4 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. This makes it an attractive target for cancer treatments, as drugs can be developed to inhibit or activate ST7-OT4 in order to kill or slow the growth of cancer cells.

Another study has shown that ST7-OT4 is involved in the regulation of cellular processes that are important for the development and progression of several diseases, including diabetes. This suggests that ST7-OT4 may be a potential biomarker for diabetes, as new treatments can be developed to regulate its expression and activity.

In addition to its potential as a drug target and biomarker, ST7-OT4 also has potential as a therapeutic agent. Studies have shown that ST7-OT4 can be used to knockdown the expression of genes that are involved in cancer growth and progression, as well as in the regulation of cellular processes that are important for the development of several diseases. This suggests that ST7-OT4 may be a useful tool for the development of new treatments for a variety of diseases.

Overall, ST7-OT4 is a unique and promising molecule that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its role and potential as a therapeutic agent.

Protein Name: ST7 Overlapping Transcript 4

The "ST7-OT4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ST7-OT4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets